Obesity, NAFLD/NASH, and Diabetes

被引：0
|
作者：
Prattichizzo, Francesco [1 ]
Ceriello, Antonio [1 ]
Shah, Viral N. [2 ]
机构：
[1] IRCCS MultiMed, Milan, Italy
[2] Univ Colorado Anschutz Med Campus, Barbara Davis Ctr Diabet, Aurora, CO USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2024年 / 26卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1089/dia.2024.2516
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S231 / S240
页数：10
相关论文
共 50 条
  • [1] NAFLD/NASH and Diabetes
    Garg, Kavita
    Brackett, Scott
    Hirsch, Irl B.
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : S174 - S186
  • [2] NAFLD and NASH and Diabetes
    Garg, Kavita
    Reinicke, Trenton
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : S198 - S205
  • [3] Epidemiological aspects of obesity and NASH/NAFLD in Japan
    Yoshiike, N
    Lwin, M
    HEPATOLOGY RESEARCH, 2005, 33 (02) : 77 - 82
  • [4] Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH
    Vilalta, Adrian
    Gutierrez, Julio A.
    Chaves, SuZanne
    Hernandez, Moises
    Urbina, Silvia
    Hompesch, Marcus
    ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (03)
  • [5] Antidiabetic TIX100 Improves NAFLD/NASH in Mice With and Without Diabetes and Obesity
    Jo, Seongho
    Chen, Junqin
    Jing, Gu
    Habegger, Kirk M.
    Shalev, Anath
    DIABETES, 2023, 72
  • [6] A TELEMEDICINE PILOT FOR DIABETES WITH APPLICABILITY TO NAFLD/NASH
    John, Tina
    Elsaid, Mohamed
    Rustgi, Vinod K.
    HEPATOLOGY, 2019, 70 : 455A - 455A
  • [7] Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
    Kim, Hyunmi
    Lee, Da Som
    An, Tae Hyeon
    Park, Hyun-Ju
    Kim, Won Kon
    Bae, Kwang-Hee
    Oh, Kyoung-Jin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [8] NAFLD/NASH IN TYPE 1 DIABETES: OVERRATED OR UNDERAPPRECIATED
    De Block, C.
    Mertens, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A5 - A5
  • [9] NAFLD/NASH
    Bugianesi, Elisabetta
    Petta, Salvatore
    JOURNAL OF HEPATOLOGY, 2022, 77 (02) : 549 - 550
  • [10] Mitochondrial Protonophores For Treatment of NAFLD/NASH and Type 2 Diabetes
    Shulman, Gerald I.
    FASEB JOURNAL, 2016, 30
12345